Cost-effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation

被引：0
|
作者：
Shah, Shimoli V. [1 ]
Gage, Brian F. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Cost-effectiveness; Atrial fibrillation; Thrombin inhibitors; Stroke; Anticoagulants;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16179
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
    Kansal, Anuraag R.
    Sorensen, Sonja V.
    Gani, Ray
    Robinson, Paul
    Pan, Feng
    Plumb, Jonathan M.
    Cowie, Martin R.
    HEART, 2012, 98 (07) : 573 - 578
  • [22] COST-EFFECTIVENESS OF DABIGATRAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN AUSTRALIA
    Tilden, D.
    Germanos, P.
    Gordon, J.
    Tocchini, L.
    Monz, B.
    VALUE IN HEALTH, 2011, 14 (07) : A375 - A375
  • [23] COST-EFFECTIVENESS ANALYSIS OF DABIGATRAN COMPARED TO WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN A MEDICARE POPULATION
    Ward, M. A.
    Biddle, A. K.
    VALUE IN HEALTH, 2012, 15 (04) : A121 - A121
  • [24] COST-EFFECTIVENESS OF WARFARIN AND ASPIRIN FOR PROPHYLAXIS OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION
    GAGE, BF
    CARDINALLI, AB
    ALBERS, GW
    OWENS, DK
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (23): : 1839 - 1845
  • [25] COST-EFFECTIVENESS OF DABIGATRAN VERSUS WARFARIN IN ATRIAL FIBRILLATION MANAGEMENT IN COLOMBIA
    Alfonso-Cristancho, R.
    Herran, S.
    Caicedo, M.
    Gomez, E.
    VALUE IN HEALTH, 2011, 14 (07) : A536 - A537
  • [26] COST-EFFECTIVENESS OF DABIGATRAN FOR THROMBOEMBOLIC EVENTS PREVENTION IN ATRIAL FIBRILLATION PATIENTS
    Abbott, T.
    Armijo, N.
    Balmaceda, C.
    Espinoza, M. A.
    VALUE IN HEALTH, 2022, 25 (12) : S152 - S152
  • [27] Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden
    Davidson, Thomas
    Husberg, Magnus
    Janzon, Magnus
    Oldgren, Jonas
    Levin, Lars-Ake
    EUROPEAN HEART JOURNAL, 2013, 34 (03) : 177 - 183
  • [28] COST-EFFECTIVENESS ANALYSIS COMPARING DABIGATRAN AND ADJUSTED-DOSE WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
    Zhao, Y.
    Lim, L.
    Coleman, C., I
    VALUE IN HEALTH, 2011, 14 (03) : A41 - A41
  • [29] COST-EFFECTIVENESS OF EDOXABAN, APIXABAN, RIVAROXABAN AND DABIGATRAN VERSUS WARFARIN FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
    Marchetti, M.
    Liberato, N. L.
    Rognoni, C.
    Quaglini, S.
    HAEMATOLOGICA, 2014, 99 : 487 - 487
  • [30] Cost-effectiveness of Dabigatran Compared With Rivaroxaban for Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in China
    Dong, Shu-Jie
    Wu, Bin
    Zhai, Suo-Di
    Zhang, Yan-Jun
    Chu, Yun-Bo
    Gupta, Parul
    Li, Ya-Huei
    CLINICAL THERAPEUTICS, 2020, 42 (01) : 144 - 156
12345